F8-KO

Nomenclature

B6.129S-F8tm1Smoc

Cat. NO.

NM-KO-00012

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
F8

Model Description

F8-KO mice (Stock No.NM-KO-00012)carry a knockout allele derived from the targeted deletion of exon 16-19. While F8-KO(2) mice (Stock No.NM-KO-200608) carrying the exon 1-26 deletion.
Research Application:Hemophilia A;HEMA

Disease Connection

Factor Viii Deficiency

Validation Data


微信截图_20220215125618.png

Fig 1. Schematic diagram for the F8 gene knockout mice generation strategy

4.png

Fig2. Analysis of activated partial thromboplastin time (APTT) in the F8 knock-out mice. The coagulation time in F8-KO mice (NM-KO-00012) was significantly longer than wild-type, and there was no obvious difference in coagulation time between F8-KO (NM-KO-00012) and F8-KO(2) (NM-KO-200608).


F8 gene knockout mice are an ideal animal model for studying the pathogenesis and drug screening of hemophilia A at the whole animal level. In addition, F8 gene knockout mice can provide an ideal animal model and a novel research tool for the screening and evaluation of hemophilia A drugs as well as the gene therapy of hemophilia A. F8 gene knockout mice provide an effective tool for further elucidating the pathogenesis of hemophilia A, for the evaluation and screening of drugs used for the prevention and treatment of hemophilia A, and for the development of new therapies.


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more